In a report released today, Geoff Meacham from Citi maintained a Hold rating on Pfizer (PFE – Research Report), with a price target of $23.00.

Morgan Stanley analyst Terence Flynn notes that Pfizer (PFE) announced that after a review of the totality of the data for its pipeline oral ...

Few companies embody the term 'pharma giant' as much as Pfizer. Here we take a look at the colourful history of one of the biggest drugmakers in the world. Pfizer was founded in 1849 by two recent ...

Comcast has been losing broadband subscribers to wireless giants such as AT&T, T-Mobile and Verizon, which offer plans, ...

GSK resolves patent lawsuit against Pfizer over RSV vaccines British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory syncytial ...

Pfizer is advancing on a broad front in its attempt to catch up with Novo Nordisk and Eli Lilly in the obesity drug category – but has now decided on a lead candidate. The company said that ...

Trey Paul is a CNET senior editor covering broadband. His 20+ years of experience as a writer and editor include time at the broadband marketplace Allconnect, as well as working with clients like ...

If there's anything else to say t-mobile is need to go back to the $50 dollar pre pay monthly and beat the competition right out. Use are good, I'd not ever had no issue, service has been great.

DALLAS— Luka Doncic entered the court with the Los Angeles Lakers for his first game back in Dallas to cheers in an arena where draped over every seat was a T-shirt with “Hvala za vse ...

Pfizer is ending development of its once-daily obesity pill danuglipron after a trial participant suffered possible liver injury. The decision halts early-stage testing and cancels plans for ...